Skip to main content
Equibles
ROIV $36.80 +5.38%
ROIV logo
ROIV · Roivant Sciences Ltd.
Track ROIV — free

Use ROIV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ROIV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$36.80 +1.88 (+5.38%) At close · Oct 21
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$25.22B
Shares
722.32M
Volume · Oct 21 16.84M Avg daily vol (3M) 7.25M
All webcasts

Earnings call · FY2026 Q4

Roivant Sciences Ltd. (ROIV) Q4 2026 Earnings Call

Concluded May 20, 2026
May 20, 2026 0 turns
Period
FY2026 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $2.52M -66.7% YoY
Net income · derived Q4 $302.99M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Mosliciguat PH-ILD Phase 2B 26 Period 2 randomized withdrawal readout 26 Commercial launch execution 21 Patient population / refractory characteristics 6 Non-responder / subset analysis pending 4 Modernta litigation settlement / cash inflow 2

Management tone

Confident

Net tone +82 · low hedging

Grounding quotes
  • “we continue to see just tremendous execution of momentum across our development portfolio”
  • “you can't fake ACR 70s like this”
  • “this is beating that far handily”

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 20, 2026 10-K report Filed May 20, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

ROIV alerts

Roivant Sciences Ltd.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →